NCT00001105View on ClinicalTrials.gov

The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1996

Conditions
HIV Infections
Interventions
DRUG

F105 Monoclonal Antibody (Human)

Trial Locations (1)

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001105 - The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV | Biotech Hunter | Biotech Hunter